Legend Biotech Corp
NASDAQ:LEGN

Watchlist Manager
Legend Biotech Corp Logo
Legend Biotech Corp
NASDAQ:LEGN
Watchlist
Price: 39.89 USD 1.37% Market Closed
Market Cap: 7.4B USD
Have any thoughts about
Legend Biotech Corp?
Write Note

Legend Biotech Corp
Cash Interest Paid

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Legend Biotech Corp
Cash Interest Paid Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Cash Interest Paid Analysis
Latest Figures & CAGR of Competitors

Company Cash Interest Paid CAGR 3Y CAGR 5Y CAGR 10Y
Legend Biotech Corp
NASDAQ:LEGN
Cash Interest Paid
$1.4m
CAGR 3-Years
91%
CAGR 5-Years
69%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Cash Interest Paid
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Gilead Sciences Inc
NASDAQ:GILD
Cash Interest Paid
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Amgen Inc
NASDAQ:AMGN
Cash Interest Paid
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Cash Interest Paid
$40.8m
CAGR 3-Years
-10%
CAGR 5-Years
-7%
CAGR 10-Years
21%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Cash Interest Paid
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Legend Biotech Corp's Cash Interest Paid?
Cash Interest Paid
1.4m USD

Based on the financial report for Dec 31, 2023, Legend Biotech Corp's Cash Interest Paid amounts to 1.4m USD.

What is Legend Biotech Corp's Cash Interest Paid growth rate?
Cash Interest Paid CAGR 5Y
69%

Over the last year, the Cash Interest Paid growth was 179%. The average annual Cash Interest Paid growth rates for Legend Biotech Corp have been 91% over the past three years , 69% over the past five years .

Back to Top